IGFBP4 anticorps (AA 96-124)

N° du produit ABIN3031356

Cet anticorps anti-IGFBP4 est un anticorps Lapin Polyclonal détectant IGFBP4 dans WB, IHC et ELISA. Adapté pour Humain et Souris.

Aperçu rapide pour IGFBP4 anticorps (AA 96-124) (ABIN3031356)

Antigène: IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IGFBP4 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Détail du produit anti-IGFBP4 anticorps

Épitope: AA 96-124

Réactivité croisée (Details): Expected species reactivity: Bovine, Pig

Purification: Antigen affinity purified

Immunogène: A portion of amino acids 96-124 from the human protein was used as the immunogen for this IGFBP4 antibody.

Isotype: Ig Fraction

Information d'application

Indications d'application: Titration of the IGFBP4 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,IHC (Paraffin): 1:10-1:50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the IGFBP4 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Détails sur IGFBP4

Antigène: IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))

Autre désignation: IGFBP4

Sujet: This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.

UniProt: P22692

Pathways: Signalisation WNT, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process